Individual patients will experience a variable time to onset and degree of symptom relief.For patients who do not respond adequately to the starting dosage after 2 weeks of therapy, replacing the current strength of Wixela™ Inhub™ with a higher strength may provide additional improvement in asthma control.If a previously effective dosage regimen fails to provide adequate improvement in asthma control, the therapeutic regimen should be reevaluated and additional therapeutic options (e.g., replacing the current strength of Wixela™ Inhub™ with a higher strength, adding additional ICS, initiating oral corticosteroids) should be considered.For patients with asthma aged 4 to 11 years who are not controlled on an ICS, the dosage is 1 inhalation of Wixela™ Inhub™ 100/50 twice daily, approximately 12 hours apart.The recommended dosage for patients with COPD is 1 inhalation of Wixela™ Inhub™ 250/50 twice daily, approximately 12 hours apart.If shortness of breath occurs in the period between doses, an inhaled, short-acting betaAlways consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.The easiest way to lookup drug information, identify pills, check interactions and set up your own personal medication records. Print free coupons for wixela inhub and find the best deal on your prescription medications today Get 7 Mylan coupon codes and promo codes at CouponBirds. Inflammation Of The Tissue Lining The Sinuses 6. Uses. 19 Coupons. A Common Cold 2. The diskus is used to treat both COPD and asthma. Completing the CAPTCHA proves you are a human and gives you temporary access to the web property.If you are on a personal connection, like at home, you can run an anti-virus scan on your device to make sure it is not infected with malware.If you are at an office or shared network, you can ask the network administrator to run a scan across the network looking for misconfigured or infected devices. WIXELA INHUB is for adults and children with asthma who are not well controlled with an asthma control medicine, such as an inhaled corticosteroid (ICS) medicine and need both an ICS and long-acting betaWIXELA INHUB 250/50 is a twice-daily prescription medicine used long term to treat chronic obstructive pulmonary disease (COPD), including chronic bronchitis, emphysema, or both, for better breathing and fewer flare-ups.WIXELA INHUB is not used to relieve sudden breathing problems from asthma or COPD and won't replace a rescue inhaler.WIXELA INHUB is a twice-daily prescription medicine used to control symptoms of asthma and to prevent symptoms such as wheezing in patients 4 years and older. This product is used to control and prevent symptoms (wheezing and shortness of breath) caused by asthma or ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). If asthma symptoms arise in the period between doses, an inhaled, short-acting betaFor patients aged 12 years and older, the dosage is 1 inhalation twice daily, approximately 12 hours apart.When choosing the starting dosage strength of Wixela™ Inhub™, consider the patients’ disease severity, based on their previous asthma therapy, including the ICS dosage, as well as the patients’ current control of asthma symptoms and risk of future exacerbation.The maximum recommended dosage is Wixela™ Inhub™ 500/50 twice daily.Improvement in asthma control following inhaled administration of Wixela™ Inhub™ can occur within 30 minutes of beginning treatment, although maximum benefit may not be achieved for 1 week or longer after starting treatment. More frequent administration or a greater number of inhalations (more than 1 inhalation twice daily) of the prescribed strength of Wixela™ Inhub™ is not recommended as some patients are more likely to experience adverse effects with higher doses of salmeterol. Available for Android and iOS devices. Choosing to participate in a study is an important personal decision. If you are using more than 1 inhaled drug, ask the doctor which drug to use first. About Wixela Inhub (Generic) Overview How to use Side effects Precautions Storage Drug interactions Overdose More This product is used to control and prevent symptoms (wheezing and shortness of breath) caused by asthma or ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). If experienced, these tend to have a Severe expression 1. Patients using Wixela™ Inhub™ should not use additional LABA for any reason.